Home > Resources > Videos > Pharma must get out of its own way to advance digitally

Pharma must get out of its own way to advance digitally

September 18, 2019

RJ Lewis Founder & CEO eHealthcare Solutions explains why it's important for pharma to take risks and conduct A/B testing to find and implement better digital solutions.

Spotlight

Hutchison MediPharma

Hutchison MediPharma (HMP) is a novel drug R&D company focusing on discovering, developing and commercializing innovative therapeutics in oncology and autoimmune diseases. With a team of over 400 scientists and staff, our pipeline is comprised of novel oral compounds for cancer and inflammation in development in North America, Europe, Australia, China and Korea. Founded in 2002, HMP's strategic partnerships involve global, innovative companies such as AstraZeneca, Eli Lilly and Nestlé Health Science in oncology and inflammation research & development.

OTHER VIDEOS

Free flowing amorphous solid dispersions for enhanced drug solubility

video | March 9, 2022

Could there be a new way to improve the solubility of poorly soluble APIs? Our newly launched microparticle technology EUDRATEC® SoluFlow is just that! It works by turning a poorly soluble drug into a free-flowing amorphous solid dispersion (ASD) that can be easily compressed into tablets or filled into capsules....

Watch Now

Optimizing Outcomes Across the Pharma Value Chain Network

video | January 20, 2022

The pharma industry faces new challenges to be more agile and flexible in the effort to produce and deliver medicines to market faster. Digitalization will play a key role in helping companies optimize their value chain network. Hear from AspenTech's David Leitham as he touches on this trend and how Industrial AI solutions will help companies stay ahead....

Watch Now

How Billionaire Mark Cuban's Online Pharmacy Went From Pitch To Reality

video | February 2, 2022

Billionaire investor Mark Cuban launched an online pharmacy that offers more than 100 generic drugs at an affordable price with a goal of being “radically transparent” in its price negotiations with drug companies....

Watch Now

Digital Health solutions for patient centric clinical trials

video | August 24, 2021

Digital health solutions for remote patient data collection and continuous patient monitoring are enabling us to reduce patient burden and accelerate our clinical trials. Halsey Lea, Director Data Science, Data Science & AI, R&D, explains the transformative role that digital connected devices are playing in our smart clinical trial programmes....

Watch Now

Free flowing amorphous solid dispersions for enhanced drug solubility

video | March 9, 2022

Could there be a new way to improve the solubility of poorly soluble APIs? Our newly launched microparticle technology EUDRATEC® SoluFlow is just that! It works by turning a poorly soluble drug into a free-flowing amorphous solid dispersion (ASD) that can be easily compressed into tablets or filled into capsules....

Watch Now

Optimizing Outcomes Across the Pharma Value Chain Network

video | January 20, 2022

The pharma industry faces new challenges to be more agile and flexible in the effort to produce and deliver medicines to market faster. Digitalization will play a key role in helping companies optimize their value chain network. Hear from AspenTech's David Leitham as he touches on this trend and how Industrial AI solutions will help companies stay ahead....

Watch Now

How Billionaire Mark Cuban's Online Pharmacy Went From Pitch To Reality

video | February 2, 2022

Billionaire investor Mark Cuban launched an online pharmacy that offers more than 100 generic drugs at an affordable price with a goal of being “radically transparent” in its price negotiations with drug companies....

Watch Now

Digital Health solutions for patient centric clinical trials

video | August 24, 2021

Digital health solutions for remote patient data collection and continuous patient monitoring are enabling us to reduce patient burden and accelerate our clinical trials. Halsey Lea, Director Data Science, Data Science & AI, R&D, explains the transformative role that digital connected devices are playing in our smart clinical trial programmes....

Watch Now
MORE VIDEOS

Spotlight

Hutchison MediPharma

Hutchison MediPharma (HMP) is a novel drug R&D company focusing on discovering, developing and commercializing innovative therapeutics in oncology and autoimmune diseases. With a team of over 400 scientists and staff, our pipeline is comprised of novel oral compounds for cancer and inflammation in development in North America, Europe, Australia, China and Korea. Founded in 2002, HMP's strategic partnerships involve global, innovative companies such as AstraZeneca, Eli Lilly and Nestlé Health Science in oncology and inflammation research & development.

Events